Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Patients receiving nutritional emulsion for at least 3 days will be treated with Hirudoid
cream or placebo cream to prevent and treat phlebitis caused by the infusion. The treatment
is continued after the end of infusion for at least 7 days.
Number of patients developing superficial phlebitis and duration of phlebitis will be
recorded.